Who We Fund
Since 1949, LLS has provided more than $1.7 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Jonathan Licht
DNA biology, myeloma
Caroline Arber
myeloma CAR-T
Bruno Paiva
smoldering myeloma
Matteo Bellone
Smoldering multiple myeloma
Ricky Johnstone
lymphoma and myeloma
Lawrence Boise
CART and myeloma
Helen Heslop
Immunotherapy
Madhav Dhodapkar
multiple myeloma immunotherapy
Alfred Garfall
myeloma immunotherapy
David Fruman
novel combinations
Brian Walker
smoldering myeloma, MGUS
Jun Qi
Myeloma
Suzanne Lentzsch
Myeloma
Ruben Carrasco
Myeloma
Gareth Morgan
smoldering myeloma, MGUS
Simona Colla
Myeloma biology
Armin Rashidi
gut bacteria and transplant success
Sigurður Kristinsson
Smoldering myeloma
John Leonard
lymphoma research
Amin Sobh
Myeloma biology
Nizar Bahlis
Myeloma immunotherapy
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Tanya Siddiqi
clinical trial access
Carl June
CAR T immunotherapy
Qing Yi
Novel CAR-T
Jianhua Yu
myeloma immunotherapy
Shirong Li
myeloma
Mala Shanmugam
myeloma
Robert Orlowski
(Smoldering) Multiple Myeloma
Jing Yang
Myeloma
Lev Kats
myeloma and epigenetics
Eugenio Morelli
Myeloma
Christopher Flowers
clinical trial access
F. Lennie Wong
Equity in Access
Noemí Puig Morón
Myeloma
William Matsui
Myeloma
Alec Zhang
myeloma, immunotherapy